SCHEMBL4647558

SCHEMBL4647558

O=S(=O)(O)c1cc(-c2ccc3ncccc3c2)cc2c1OCC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.47
POLB P06746 2/20 0.47
RAB9A P51151 1/20 0.47
DYRK1A Q13627 2/20 0.43
MCL1 Q07820 1/20 0.41
GSK3B P49841 1/20 0.40
AR P10275 1/20 0.36
PFKFB3 Q16875 1/20 0.36
MET P08581 2/20 0.35
ADORA2A P29274 1/20 0.35
HPGD P15428 1/20 0.35
CCNC P24863 1/20 0.35
CDK8 P49336 1/20 0.35
PIK3CA P42336 1/20 0.35
HSD17B1 P14061 1/20 0.35
HSD17B2 P37059 1/20 0.35
CHRM5 P08912 1/20 0.35
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4648576 0.85 CA12 (0.43) PIK3CA
SCHEMBL4739374 0.81 MCL1 (0.59) NPC1POLBRAB9ADYRK1AMCL1
SCHEMBL4648140 0.77 GRIA2 (0.40)
SCHEMBL4648162 0.76 NRP1 (0.40) PIK3CA
SCHEMBL4649007 0.76 HSD17B1 (0.38) DYRK1AHSD17B1KMT2A
SCHEMBL4647930 0.75 PDE4B (0.40)
SCHEMBL4646451 0.74 NRP1 (0.33) POLBDYRK1APIK3CAMEN1MAPT
SCHEMBL4645575 0.74 MAPT (0.38) DYRK1AGSK3BMEN1MAPTKMT2A
SCHEMBL4648553 0.74 PARP1 (0.41) NPC1RAB9ADYRK1AMAPT
SCHEMBL4648561 0.74 PTPN1 (0.40) PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255117-A1 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-10-16 US claimed
WO-2008104597-A2 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-09-04 WO claimed
EP-1964834-A1 Sulphonyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-09-03 EP claimed
US-20080255117-A1 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-10-16 US disclosed
WO-2008104597-A2 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-09-04 WO disclosed
EP-1964834-A1 Sulphonyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255117-A1 SULFONYLTRYPTOPHANOLS FSHR, NPY1R, GNRHR NPC1 3176/4885POLB 4691/4885RAB9A 2871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.